TNF and rheumatoid arthritis: The injection of β-glucans increases clinical scores in mice by enhancing TNF secretion, autoantibody production and macrophage glycolysis78,81, whereas treatment with 2-deoxy-ᴅ-glucose, a nonmetabolizable glucose analog, reduces RA severity by inhibiting metabolic reprogramming83.